GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pakistan Ltd (KAR:GLAXO) » Definitions » FCF Yield %

GlaxoSmithKline Pakistan (KAR:GLAXO) FCF Yield % : 3.22 (As of Mar. 31, 2025)


View and export this data going back to 1953. Start your Free Trial

What is GlaxoSmithKline Pakistan FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, GlaxoSmithKline Pakistan's Trailing 12-Month Free Cash Flow is ₨4,288 Mil, and Market Cap is ₨133,256 Mil. Therefore, GlaxoSmithKline Pakistan's FCF Yield % for today is 3.22%.

The historical rank and industry rank for GlaxoSmithKline Pakistan's FCF Yield % or its related term are showing as below:

KAR:GLAXO' s FCF Yield % Range Over the Past 10 Years
Min: -31.66   Med: 2.93   Max: 12.6
Current: 3.22


During the past 13 years, the highest FCF Yield % of GlaxoSmithKline Pakistan was 12.60%. The lowest was -31.66%. And the median was 2.93%.

KAR:GLAXO's FCF Yield % is ranked better than
69.72% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 0.11 vs KAR:GLAXO: 3.22

GlaxoSmithKline Pakistan's FCF Margin % for the quarter that ended in Sep. 2024 was 14.23%.


GlaxoSmithKline Pakistan FCF Yield % Historical Data

The historical data trend for GlaxoSmithKline Pakistan's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Pakistan FCF Yield % Chart

GlaxoSmithKline Pakistan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.39 7.60 8.47 -16.79 -0.21

GlaxoSmithKline Pakistan Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.78 14.73 -5.34 13.79 13.69

Competitive Comparison of GlaxoSmithKline Pakistan's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, GlaxoSmithKline Pakistan's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Pakistan's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pakistan's FCF Yield % distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Pakistan's FCF Yield % falls into.


;
;

GlaxoSmithKline Pakistan FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

GlaxoSmithKline Pakistan's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-54.232 / 26429.57633
=-0.21%

GlaxoSmithKline Pakistan's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=2096.378 * 4 / 61267.0219
=13.69%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GlaxoSmithKline Pakistan FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


GlaxoSmithKline Pakistan FCF Yield % Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pakistan's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Pakistan Business Description

Traded in Other Exchanges
N/A
Address
35, Dockyard Road, West Wharf, Karachi, PAK, 74000
GlaxoSmithKline Pakistan Ltd is engaged in research, development, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. It is involved in Anti-infective, Respiratory, Vaccines, Dermatological, Gastrointestinal, Analgesics, Urology, Central Nervous System, Allergy, Cardiovascular and Vitamins therapy areas. The operating business divisions are Pharmaceuticals and Consumer Healthcare. The pharmaceutical brands of the company include Augmentin, Seretide, Amoxil, Velosef, Zantac and Calpol and prominent vaccines include Synflorix, Infanrix Hexa, Rotarix, Engerix-B, Havrix, and Cervarix. The company derives maximum revenue from Pharmaceuticals segment.

GlaxoSmithKline Pakistan Headlines

No Headlines